Investors

Trellus Health^® provides digital chronic condition management solutions for employers and health plans using the GRITT™ resilience-based methodology and a proprietary HIPAA-compliant platform, Trellus Elevate^® , for remote telemedicine care. Initially focused on Inflammatory Bowel Diseases (IBD), including Crohn’s Disease and ulcerative colitis, Trellus sees potential for broader chronic condition applications. The Trellus Elevate^® platform integrates resilience-based care validated by clinical research at Mount Sinai, showing over 85% reduction in unplanned healthcare use. Founded in July 2020, Trellus holds exclusive licensing for GRITT™ commercialization from ISMMS.

Kevin L. Murphy, Jr. is an experienced senior healthcare leader with a demonstrated history of growing profitable businesses within the healthcare, insurance & pharmacy industries. Mr. Murphy retired from CVS Health after almost a dozen years where he led organizations for CVS in rare disease management, specialty and infusion and the retail pharmacy segments. Mr. Murphy has a long track record in healthcare including pharmacy benefit management, specialty pharmacy, rare disease management, insurance and healthcare consulting industries. His senior executive roles included responsibility for P&L’s, acquisitions, joint ventures, de-novo startups, turn-arounds, business development, account management, product development and overall healthcare management. Mr. Murphy graduated with a B.S. in management from University of Rhode Island and an M.S. in Finance from Fairfield University. He is an active board member for BlueCross BlueShield RI & the American Lung Association, NE & Mid Atlantic.